Moleculin Biotech, Inc. MBRX

Moleculin Biotech, Inc. is a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Our lead product candidate is Annamycin, a Phase II clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as AML. We also have two active pre-clinical small molecule portfolios, one of which is focused on the modulation of ha

OVERVIEW

The site ir.moleculin.com currently has an average traffic ranking of zero (the lower the more users). We have inspected ten pages within the site ir.moleculin.com and found twenty-one websites interfacing with ir.moleculin.com. There is four public media sites enjoyed by this website.
Pages Crawled
10
Links to this site
21
Social Links
4

IR.MOLECULIN.COM TRAFFIC

The site ir.moleculin.com has seen diverging levels of traffic for the whole of the year.
Traffic for ir.moleculin.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.moleculin.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.moleculin.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO DOMAIN

Moleculin Biotech - Moleculin Biotech, Inc. is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Eac

is a pre-clinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M. Each of our projects represents a breakthrough discovery and a highly disruptive technology. Advancing breakthrough therapeutic approaches to cancer.

WHAT DOES IR.MOLECULIN.COM LOOK LIKE?

Desktop Screenshot of ir.moleculin.com Mobile Screenshot of ir.moleculin.com Tablet Screenshot of ir.moleculin.com

IR.MOLECULIN.COM SERVER

We detected that a lone page on ir.moleculin.com took three hundred and fifty-nine milliseconds to come up. Our web crawlers could not find a SSL certificate, so in conclusion our web crawlers consider ir.moleculin.com not secure.
Load time
0.359 secs
SSL
NOT SECURE
Internet Protocol
52.8.221.80

SERVER OS

We detected that this website is employing the Apache operating system.

HTML TITLE

Moleculin Biotech, Inc. MBRX

DESCRIPTION

Moleculin Biotech, Inc. is a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Our lead product candidate is Annamycin, a Phase II clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as AML. We also have two active pre-clinical small molecule portfolios, one of which is focused on the modulation of ha

PARSED CONTENT

The site ir.moleculin.com has the following on the web page, "is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M." We noticed that the website also said " Each of our projects represents a breakthrough discovery and a highly disruptive technology." It also stated " Quarter Ended Sep 30, 2016."

SEEK MORE WEBSITES

Setou-Kaiba CEO Of KaibaCorp - DeviantArt

Forgot Password or Username? Deviant for 8 Years. This is the place where you can personalize your profile! You can drag and drop to rearrange.

Their Profile - cin125 - Skyrock.com

The position of the blocks have been saved. Franchement vous etes tres belle. Sat, December 13, 2008.

Home GeoMetronBikes

Best html web site builder software. GEOMETRON The Future of Geometry. We like these words; individual, custom, tailored, focussed, performance. Mojo has always been a performance focussed company, racing and going faster is part of why we come to work! In the process of developing this ground-breaking solution, the test riders all smashed their times both on the climbs and on the descents.

کشکول پژوهشگر

از حدود هجده سالگی برای ادامه تحصیل به مشهد و اهواز رفتم. در دانشگاه شیراز ادامه تحصیل دادم. دو رشته مهندسی کشاورزی و علوم کتابداری و اطلاع رسانی را خواندم. آموختن فنون مصاحبه از بزرگان رسانهها. مفهوم و تفاوتهای سنجه و شاخص.